Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
09/1999
09/21/1999US5955313 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded uses thereof
09/21/1999US5955283 Dna probe useful in diagnosis of diseases related to ion transport in the central and or automonic neverous system; alzheimer's/parkindon's/huntington's diseases
09/21/1999US5955257 Infusible grade short-term cell storage medium for mononuclear cells
09/21/1999US5955256 Mixing with photosensitizer and blocking agent of cysteine, n-acetylcysteine, dithiothreitol, butylated hydroxytoluene, butylated hydroxyanisole, tyrosine, histidine, tryptophan, propyl gallate, or mercaptopropionyl glycine
09/21/1999US5955110 Multilayered submucosal graft constructs and method for making the same
09/21/1999US5955086 Oregano for the treatment of internal parasites and protozoa
09/21/1999US5954971 Pumped-filter blood-processing apparatus and methods
09/21/1999CA2073741C Thromboplastin extract, reagent, and preparation thereof
09/21/1999CA2006087C Polypeptides isolated from the venom of the spider hololena curta
09/16/1999WO1999046657A2 Systems and methods for storing, retrieving, and manipulating data in medical processing devices
09/16/1999WO1999046381A2 Human fgf gene and gene expression products
09/16/1999WO1999046380A2 Human membrane spanning proteins
09/16/1999WO1999046372A2 Ribozymes capable of inhibiting the expression of the ccr5 receptor
09/16/1999WO1999046367A2 Methods of diagnosis and triage using cell activation measures
09/16/1999WO1999046366A1 Uses for humane non-autologous mesenchymal stem cells
09/16/1999WO1999046365A1 Methods and compositions for the selective expansion of gamma/delta t-cells
09/16/1999WO1999046281A2 Novel polypeptides and nucleic acids encoding the same
09/16/1999WO1999045938A1 Thrombin preparation and products and fibrin sealant methods employing same
09/16/1999WO1999045895A1 Novel powder compositions
09/16/1999WO1999045798A1 Process for producing a bio-organic calcium composition and nutrient agent containing the same
09/16/1999WO1999045783A1 Producer cells for replication selective viruses in the treatment of malignancy
09/16/1999WO1999045770A1 Skin equivalent and methods of forming and using same
09/16/1999WO1999030723A9 Use of human umbilical cord blood for adoptive therapy
09/16/1999WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
09/16/1999WO1999029329A9 Immunotherapy using ie water
09/16/1999WO1999015684A9 Expression of genes in hematopoietic stem cells in hischaemic conditions
09/16/1999DE19810947A1 Removal of biological contaminants from biological products using anion-exchange membrane
09/16/1999CA2323109A1 Ribozymes capable of inhibiting the expression of the ccr5 receptor
09/16/1999CA2323067A1 Producer cells for replication selective viruses in the treatment of malignancy
09/16/1999CA2322771A1 Human membrane spanning proteins
09/16/1999CA2322741A1 Thrombin preparation and products and fibrin sealant methods employing same
09/16/1999CA2322618A1 Methods of diagnosis and triage using cell activation measures
09/15/1999EP0941737A1 Apoptosis inducers
09/15/1999EP0941736A1 Oral immunity enhancing agent containing peptidoglycans
09/15/1999EP0941734A2 Artificial mineral water for medicinal/prophylatic purposes
09/15/1999EP0941356A2 Stabilized transient gene expression
09/15/1999EP0941339A1 Therapeutic gene
09/15/1999EP0941330A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4)
09/15/1999EP0941329A1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3)
09/15/1999EP0941326A1 Murine guanine nucleotide exchange factor (mngef) and human homologues thereof
09/15/1999EP0941321A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists
09/15/1999EP0941319A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
09/15/1999EP0941308A2 Multi-resistant bacteria, methods for obtaining them and their uses
09/15/1999EP0941252A1 Anti-p53 single-chain antibody fragments and their uses
09/15/1999EP0941245A1 Promoter for smooth muscle cell expression
09/15/1999EP0941125A1 Methods for regulating angiogenesis
09/15/1999EP0941105A1 Pretraumatic use of hemoglobin
09/15/1999EP0941103A1 Pharmaceutical composition for treatment of diabetes
09/15/1999EP0941027A1 Msc-megakaryocyte precursor composition and method of isolating mscs associated with isolated megakaryocytes by isolating megakaryocytes
09/15/1999EP0748383B1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
09/15/1999CN1228713A Method for removing tumor cells from tumor cell-contaminated stem cell products
09/15/1999CN1228330A Male Yang tonifying wine
09/15/1999CN1228328A Jingshutong soluble granules
09/15/1999CN1228327A Traditional Chinese medicine for curing gastrointestinal disease
09/15/1999CN1228321A Drug for curing stone of urinary system
09/15/1999CN1228320A Chinese patent drug for curing cirrhosis and splenceratosis disease
09/15/1999CN1228318A Chinese patent drug for curing hepatitis B
09/15/1999CN1228313A Tonifying Yang anticancer powder for alimentary canal
09/15/1999CN1228312A Externally used Chinese medicinal pill for curing tinnitus and deaf, its preparing method and use
09/15/1999CN1228310A Xiaoaisan powder for curing cancer
09/15/1999CN1228307A Medicinal product for curing skin disease
09/15/1999CN1228306A Eye drops for curing electric ophthalimia
09/15/1999CN1228305A Food capable of improving liver function
09/15/1999CN1228304A Antimicrobial composite
09/15/1999CN1045062C Medicinal bandage for curing eye disease
09/15/1999CN1045061C Drug for curing burn and scald
09/15/1999CN1045059C Medical composition for curing heat wound for homothermal animal and human and its preparing method
09/14/1999US5952482 Production of hemoglobin having a δ-like globin
09/14/1999US5952228 Isolated cytolytic T cells which are specific for complexes OF HLA- B35 molecules and the peptide PHE Pro Ser Asp Ser Trp Cys Tyr PHE, and uses thereof
09/14/1999US5952226 Hypoxia responsive EPO producing cells
09/14/1999US5952225 A packaging cell containing a polynucleotide which codes a portion of a selected retrovirus having at least the envelope protein; for producing vectors resistant to complement inactivation by serum; gene therapy
09/14/1999US5952220 Preparing a dilute viral suspension in an aqueous solution which is then nebulised with gas pressure or ultrasound; treatment of respiratory diseases, asthma, lung cancer, cystic fibrosis
09/14/1999US5952009 Administering beta-lactoglobulin wherein at least one lysine of n-terminal amino acid is modified by an aromatic anhydride selected from trimellitic anhydride, 3-hydroxyphthalic anhydride and trimellitic anhydride chloride
09/14/1999US5951977 Competitive exclusion culture for swine
09/14/1999US5951976 Vaccinating a mammal by administering a composition comprising an opsonin-enhanced cell comprising said selected antigen with the provision the opsonin does not bind to a receptor for a fragment of c33
09/14/1999US5951975 Immunization with a foreign artificial target antigen to promote a cytotoxic t-lymphocyte response; loading cultured tumor cells with antigen; deactivating the cells; immunizing with the cell to get a response to unmodified tumor
09/14/1999US5950634 Method for assessing oxidative stress and its control in humans
09/14/1999CA1340742C Process for chromatographically separating plasma proteins, protein concentrates produced, particularly factor viii, fibrinogene, von willebrand factor and fibronectin
09/13/1999CA2225876A1 Blood substitute and medical treatments
09/10/1999WO1999045127A2 Enhanced prodrug activation
09/10/1999WO1999045126A2 Enhanced prodrug activation
09/10/1999WO1999045102A1 Method for activating natural killer (nk) cells
09/10/1999WO1999045100A1 Embryonic or stem-like cell lines produced by cross-species nuclear transplantation
09/10/1999WO1999045099A1 New agent
09/10/1999WO1999044943A2 Vectors and viruses used in gene therapy
09/10/1999WO1999044625A1 Smallpox inhibitor of complement enzymes (spice) protein and methods of inhibiting complement activation
09/10/1999WO1999044582A2 Nontoxic vernix compositions and method of producing
09/10/1999WO1999044487A2 Genetic engineering of prosthetic bypass grafts
09/10/1999WO1999035255A8 Compositions and methods for regulated secretion from neuroendocrine cell lines
09/10/1999WO1999027977A3 Bone matrix, the utilization thereof, therapeutic preparation and kit
09/10/1999CA2323094A1 Embryonic or stem-like cell lines produced by cross-species nuclear transplantation
09/10/1999CA2322712A1 Method for activating natural killer (nk) cells
09/10/1999CA2322664A1 Enhanced prodrug activation
09/10/1999CA2321732A1 Nontoxic vernix compositions and method of producing
09/10/1999CA2265069A1 Oral immunity enhancing agent
09/09/1999DE19812753C1 Pharmaceutical or nutritive composition comprising a metal yeast and an active agent embedded in a matrix
09/09/1999DE19808889A1 Vektoren und Viren zur Gentherapie Vectors and viruses for gene therapy
09/08/1999EP0939828A1 Herpesvirus saimiri as viral vector
09/08/1999EP0939827A1 Lentiviral vectors
09/08/1999EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase